Multiple-delayed release antifungal product, use and formulation thereof
US7157095B2 · kind B2 · utility
2Cited by
31References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 2, 2002 |
| Grant date | Jan 2, 2007 |
| Priority date | — |
| Expiry date | Aug 2, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7048
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anti-fungal product is comprised of at least three delayed release dosages forms, each of which has a different release profile, with the Cmax for the anti-fungal product being reached in less than about twelve hours after initial release of anti-fungal from the product.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.